Gilbert Witte
Pulmonary Disease · Olean, NYNPI 1598764730
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by GSK at 36.5% of the total.
Across 142 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$964
- AstraZeneca$596
- Boehringer Ingelheim$353
- Merck$245
- Grifols USA, LLC$129
- Regeneron Healthcare Solutions, Inc.$97
- plus $255 from 12 others
What the payments were for
- Food & beverage$2,62599%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 52 | $964 |
| AstraZeneca | 27 | $596 |
| Boehringer Ingelheim | 23 | $353 |
| Merck | 10 | $245 |
| Grifols USA, LLC | 8 | $129 |
| Regeneron Healthcare Solutions, Inc. | 5 | $97 |
| Sanofi | 3 | $53 |
| Advanced Respiratory, Inc | 2 | $32 |
| Insmed, Inc. | 2 | $27 |
| Circassia Inc. | 2 | $26 |
| Mylan Specialty L.p. | 1 | $19 |
| United Therapeutics Corporation | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Philips North America LLC | 1 | $15 |
| Optinose US, Inc. | 1 | $15 |
| Valeritas, Inc. | 1 | $13 |
| Medtronic | 1 | $12 |
| Mallinckrodt Hospital Products Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$357
- IMFINZI$125
- PNEUMOVAX 23$107
How this compares
$2,640 in reported general payments places this provider in the 65th percentile of 1,115 pulmonary disease providers in New York.
Other pulmonary disease in Olean
- Jeffrey WolfGreat Neck$892K
- Keith HarrisPort Jefferson Station$832K
- Jack MannBayside$736K
- Raji AyinlaBronx$673K
- Charles PowellNew York$654K
- Nashat RabadiBuffalo$613K
- Craig ThurmJamaica$604K
- Michael MandelLarchmont$589K
- Sherif El BayadiSyracuse$571K
- Ali El AtatBrooklyn$482K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.